Myriad Genetics's market cap is currently $743.43M. The company's EPS TTM is $0.05; its P/E ratio is ―; Myriad Genetics is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
